Adverum Biotechnologies, Inc. (ADVM)

NASDAQ: ADVM · Real-Time Price · USD

4.070

-0.110 (-2.63%)

At close: Oct 24, 2025, 4:00 PM EDT

4.070

0.00 (0.00%)

Pre-market: Oct 27, 2025, 7:10 AM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2019	FY 2018	2010 - 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	2010 - 2017
Gene Therapeutics	1.00M	Log In	Log In	Log In	Log In	Upgrade
Gene Therapeutics Growth	-72.22%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2019	FY 2018	2010 - 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	2010 - 2017
United States	1.00M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-72.22%	Log In	Log In	Log In	Log In	Upgrade